Topics

Gilead partners with Lyndra to create long-acting oral HIV drugs

05:51 EDT 10 Jul 2019 | Pharmaceutical Technology

US-based Lyndra Therapeutics has signed an agreement with Gilead Sciences to develop and commercialise ultra-long acting oral therapies to treat...
Read More...

The post Gilead partners with Lyndra to create long-acting oral HIV drugs appeared first on Pharmaceutical Technology.

Original Article: Gilead partners with Lyndra to create long-acting oral HIV drugs

NEXT ARTICLE

More From BioPortfolio on "Gilead partners with Lyndra to create long-acting oral HIV drugs"

Quick Search

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...